Related Experiment Videos
Primary sclerosing cholangitis in patients with ulcerative colitis
H H Rasmussen1, J Fallingborg, P B Mortensen
1Dept. of Medical Gastroenterology, Aalborg Hospital, Denmark.
Scandinavian Journal of Gastroenterology
|September 1, 1992
Summary
Primary sclerosing cholangitis (PSC) affects 3.6% of ulcerative colitis (UC) patients with elevated alkaline phosphatase. Early cholangiography is recommended for UC patients with unexplained high ALP levels.
Area of Science:
- Gastroenterology
- Hepatology
- Internal Medicine
Background:
- Ulcerative colitis (UC) is an inflammatory bowel disease.
- Elevated alkaline phosphatase (ALP) can indicate liver issues in UC patients.
- Primary sclerosing cholangitis (PSC) is a chronic liver disease.
Purpose of the Study:
- To determine the prevalence of PSC in UC patients.
- To investigate the clinical characteristics and outcomes of PSC in UC patients.
- To establish the significance of elevated ALP in UC patients.
Main Methods:
- A 12-year retrospective study of UC patients at Aalborg Hospital.
- Investigation of patients with elevated ALP levels.
- Diagnosis of PSC through direct cholangiography.
Main Results:
- PSC was diagnosed in 11 out of 305 UC patients (3.6%) with elevated ALP.
- Mean ALP levels were 3.7 times the upper normal limit.
- Disease progression varied, with some patients developing cholangiocarcinoma.
Conclusions:
- PSC is a significant cause of elevated ALP in UC patients.
- Cholangiography is crucial for diagnosing PSC in UC patients with unexplained elevated ALP.
- Further research is needed for prognostic indicators and optimal liver transplantation timing.